Apnimed, Inc. (APMD)
14.40
+0.24
(+1.69%)
USD |
NASDAQ |
Nov 06, 10:10
Apnimed Market Cap : 599.48M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 589.49M |
| November 04, 2026 | 636.95M |
| November 03, 2026 | 626.96M |
| November 02, 2026 | 641.11M |
| October 30, 2026 | 682.75M |
| October 29, 2026 | 721.88M |
| October 28, 2026 | 797.23M |
| October 27, 2026 | 811.38M |
| October 26, 2026 | 788.90M |
| October 23, 2026 | 790.57M |
| October 22, 2026 | 771.42M |
| October 21, 2026 | 786.82M |
| October 20, 2026 | 770.59M |
| October 19, 2026 | 690.86M |
| October 16, 2026 | 739.36M |
| October 15, 2026 | 759.55M |
| October 14, 2026 | 717.30M |
| October 13, 2026 | 742.28M |
| October 12, 2026 | 775.58M |
| October 09, 2026 | 771.00M |
| October 08, 2026 | 758.51M |
| October 07, 2026 | 751.02M |
| October 06, 2026 | 776.41M |
| October 05, 2026 | 905.47M |
| October 02, 2026 | 895.48M |
| Date | Value |
|---|---|
| October 01, 2026 | 938.36M |
| September 30, 2026 | 912.13M |
| September 29, 2026 | 994.98M |
| September 28, 2026 | 902.14M |
| September 25, 2026 | 877.99M |
| September 24, 2026 | 900.47M |
| September 23, 2026 | 936.28M |
| September 22, 2026 | 1.062B |
| September 21, 2026 | 1.092B |
| September 18, 2026 | 1.207B |
| September 17, 2026 | 1.170B |
| September 16, 2026 | 1.128B |
| September 15, 2026 | 1.064B |
| September 14, 2026 | 1.064B |
| September 11, 2026 | 1.092B |
| September 10, 2026 | 1.116B |
| September 09, 2026 | 1.169B |
| September 08, 2026 | 1.199B |
| September 04, 2026 | 1.143B |
| September 03, 2026 | 133.54M |
| September 02, 2026 | 1.108B |
| September 01, 2026 | 1.069B |
| August 31, 2026 | 1.045B |
| August 28, 2026 | 1.183B |
| August 27, 2026 | 1.144B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| IGC Pharma, Inc. | 19.95M |
| Cocrystal Pharma, Inc. | 15.86M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| Arvinas, Inc. | 424.44M |
| Fulcrum Therapeutics, Inc. | 283.78M |
Market Cap Related Metrics
| PE Ratio | 6.161 |
| PS Ratio | 5.007 |
| Price | 14.40 |
| Earnings Yield | 16.23% |
| Operating PE Ratio | 25.18 |
| Normalized PE Ratio | 6.080 |